Objective: Transwomen are one of the most marginalised groups globally, with their experiences of prejudice significantly impacting their access to dental care and leading to social isolation. This study aimed to explore the experiences of transwomen in accessing oral health care services in Khyber Pakhtunkhwa, Pakistan.
Methods: A qualitative phenomenological study design was utilised to gain in-depth insights.
The purpose of this review is to report clinical outcomes of patients undergoing hip arthroscopy for femoroacetabular impingement (FAI) with initial access to the peripheral compartment (PC) of the hip. A search following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was performed in the PubMed, Embase, and Scopus databases. Studies in which clinical outcomes were reported for patients who underwent hip arthroscopy for FAI with initial access to the PC were included.
View Article and Find Full Text PDFStem cell treatment shows promise in treating conditions such as neurodegenerative disorders and spinal injuries, but its effectiveness is hampered by cell death and apoptosis. Improving the differentiation of MSCs into neural cells could enhance their therapeutic potential. The role of miR-22-3p in human dental pulp stem cells (HDPSCs), a superior alternative to treat neurodegenerative disorders, and its molecular mechanisms during neural differentiation remain elusive.
View Article and Find Full Text PDFBackground: The field of medical sciences has continuously been changing and evolving rapidly pertaining to the newly introduced practices and guidelines according to the principles of evidence-based medicine. Therefore, it is of utmost importance for the healthcare practitioners to keep themselves updated and regulated through self-directed learning.
Methodology: A cross-sectional survey was conducted to assess the readiness of self-directed learning among undergraduate medical students.
Background: Previous results from the KEYNOTE-716 trial demonstrated significantly improved recurrence-free survival (RFS) and distant metastasis-free survival (DMFS) with adjuvant pembrolizumab versus placebo in patients with resected stage IIB or IIC melanoma. We present a post hoc analysis of efficacy according to primary tumor location.
Methods: KEYNOTE-716 (NCT03553836) is a randomized, multicenter, double-blind, phase III study.